Regenerative medicine as applied to solid organ transplantation: Current status and future challenges

Giuseppe Orlando, Pedro Baptista, Martin Birchall, Paolo De Coppi, Alan Farney, Nadia K. Guimaraes-Souza, Emmanuel Opara, Jeffrey Rogers, Dror Seliktar, Keren Shapira-Schweitzer, Robert J. Stratta, Anthony Atala, Kathryn J. Wood, Shay Soker

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

In the last two decades, regenerative medicine has shown the potential for "bench-to-bedside" translational research in specific clinical settings. Progress made in cell and stem cell biology, material sciences and tissue engineering enabled researchers to develop cutting-edge technology which has lead to the creation of nonmodular tissue constructs such as skin, bladders, vessels and upper airways. In all cases, autologous cells were seeded on either artificial or natural supporting scaffolds. However, such constructs were implanted without the reconstruction of the vascular supply, and the nutrients and oxygen were supplied by diffusion from adjacent tissues. Engineering of modular organs (namely, organs organized in functioning units referred to as modules and requiring the reconstruction of the vascular supply) is more complex and challenging. Models of functioning hearts and livers have been engineered using "natural tissue" scaffolds and efforts are underway to produce kidneys, pancreata and small intestine. Creation of custom-made bioengineered organs, where the cellular component is exquisitely autologous and have an internal vascular network, will theoretically overcome the two major hurdles in transplantation, namely the shortage of organs and the toxicity deriving from lifelong immunosuppression. This review describes recent advances in the engineering of several key tissues and organs. Transplant International

Original languageEnglish
Pages (from-to)223-232
Number of pages10
JournalTransplant International
Volume24
Issue number3
DOIs
StatePublished - Mar 1 2011
Externally publishedYes

Fingerprint

Regenerative Medicine
Organ Transplantation
Blood Vessels
Tissue Scaffolds
Translational Medical Research
Tissue Engineering
Immunosuppression
Small Intestine
Cell Biology
Pancreas
Urinary Bladder
Stem Cells
Transplantation
Research Personnel
Oxygen
Technology
Transplants
Kidney
Food
Skin

Keywords

  • decellularization
  • extracellular matrix
  • regenerative medicine
  • scaffold
  • solid organ transplantation
  • stem cells
  • tissue engineering

ASJC Scopus subject areas

  • Transplantation

Cite this

Orlando, G., Baptista, P., Birchall, M., De Coppi, P., Farney, A., Guimaraes-Souza, N. K., ... Soker, S. (2011). Regenerative medicine as applied to solid organ transplantation: Current status and future challenges. Transplant International, 24(3), 223-232. https://doi.org/10.1111/j.1432-2277.2010.01182.x

Regenerative medicine as applied to solid organ transplantation : Current status and future challenges. / Orlando, Giuseppe; Baptista, Pedro; Birchall, Martin; De Coppi, Paolo; Farney, Alan; Guimaraes-Souza, Nadia K.; Opara, Emmanuel; Rogers, Jeffrey; Seliktar, Dror; Shapira-Schweitzer, Keren; Stratta, Robert J.; Atala, Anthony; Wood, Kathryn J.; Soker, Shay.

In: Transplant International, Vol. 24, No. 3, 01.03.2011, p. 223-232.

Research output: Contribution to journalArticle

Orlando, G, Baptista, P, Birchall, M, De Coppi, P, Farney, A, Guimaraes-Souza, NK, Opara, E, Rogers, J, Seliktar, D, Shapira-Schweitzer, K, Stratta, RJ, Atala, A, Wood, KJ & Soker, S 2011, 'Regenerative medicine as applied to solid organ transplantation: Current status and future challenges', Transplant International, vol. 24, no. 3, pp. 223-232. https://doi.org/10.1111/j.1432-2277.2010.01182.x
Orlando, Giuseppe ; Baptista, Pedro ; Birchall, Martin ; De Coppi, Paolo ; Farney, Alan ; Guimaraes-Souza, Nadia K. ; Opara, Emmanuel ; Rogers, Jeffrey ; Seliktar, Dror ; Shapira-Schweitzer, Keren ; Stratta, Robert J. ; Atala, Anthony ; Wood, Kathryn J. ; Soker, Shay. / Regenerative medicine as applied to solid organ transplantation : Current status and future challenges. In: Transplant International. 2011 ; Vol. 24, No. 3. pp. 223-232.
@article{2d3b40e84711436f85f3d92064e07b04,
title = "Regenerative medicine as applied to solid organ transplantation: Current status and future challenges",
abstract = "In the last two decades, regenerative medicine has shown the potential for {"}bench-to-bedside{"} translational research in specific clinical settings. Progress made in cell and stem cell biology, material sciences and tissue engineering enabled researchers to develop cutting-edge technology which has lead to the creation of nonmodular tissue constructs such as skin, bladders, vessels and upper airways. In all cases, autologous cells were seeded on either artificial or natural supporting scaffolds. However, such constructs were implanted without the reconstruction of the vascular supply, and the nutrients and oxygen were supplied by diffusion from adjacent tissues. Engineering of modular organs (namely, organs organized in functioning units referred to as modules and requiring the reconstruction of the vascular supply) is more complex and challenging. Models of functioning hearts and livers have been engineered using {"}natural tissue{"} scaffolds and efforts are underway to produce kidneys, pancreata and small intestine. Creation of custom-made bioengineered organs, where the cellular component is exquisitely autologous and have an internal vascular network, will theoretically overcome the two major hurdles in transplantation, namely the shortage of organs and the toxicity deriving from lifelong immunosuppression. This review describes recent advances in the engineering of several key tissues and organs. Transplant International",
keywords = "decellularization, extracellular matrix, regenerative medicine, scaffold, solid organ transplantation, stem cells, tissue engineering",
author = "Giuseppe Orlando and Pedro Baptista and Martin Birchall and {De Coppi}, Paolo and Alan Farney and Guimaraes-Souza, {Nadia K.} and Emmanuel Opara and Jeffrey Rogers and Dror Seliktar and Keren Shapira-Schweitzer and Stratta, {Robert J.} and Anthony Atala and Wood, {Kathryn J.} and Shay Soker",
year = "2011",
month = "3",
day = "1",
doi = "10.1111/j.1432-2277.2010.01182.x",
language = "English",
volume = "24",
pages = "223--232",
journal = "Transplant International",
issn = "0934-0874",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Regenerative medicine as applied to solid organ transplantation

T2 - Current status and future challenges

AU - Orlando, Giuseppe

AU - Baptista, Pedro

AU - Birchall, Martin

AU - De Coppi, Paolo

AU - Farney, Alan

AU - Guimaraes-Souza, Nadia K.

AU - Opara, Emmanuel

AU - Rogers, Jeffrey

AU - Seliktar, Dror

AU - Shapira-Schweitzer, Keren

AU - Stratta, Robert J.

AU - Atala, Anthony

AU - Wood, Kathryn J.

AU - Soker, Shay

PY - 2011/3/1

Y1 - 2011/3/1

N2 - In the last two decades, regenerative medicine has shown the potential for "bench-to-bedside" translational research in specific clinical settings. Progress made in cell and stem cell biology, material sciences and tissue engineering enabled researchers to develop cutting-edge technology which has lead to the creation of nonmodular tissue constructs such as skin, bladders, vessels and upper airways. In all cases, autologous cells were seeded on either artificial or natural supporting scaffolds. However, such constructs were implanted without the reconstruction of the vascular supply, and the nutrients and oxygen were supplied by diffusion from adjacent tissues. Engineering of modular organs (namely, organs organized in functioning units referred to as modules and requiring the reconstruction of the vascular supply) is more complex and challenging. Models of functioning hearts and livers have been engineered using "natural tissue" scaffolds and efforts are underway to produce kidneys, pancreata and small intestine. Creation of custom-made bioengineered organs, where the cellular component is exquisitely autologous and have an internal vascular network, will theoretically overcome the two major hurdles in transplantation, namely the shortage of organs and the toxicity deriving from lifelong immunosuppression. This review describes recent advances in the engineering of several key tissues and organs. Transplant International

AB - In the last two decades, regenerative medicine has shown the potential for "bench-to-bedside" translational research in specific clinical settings. Progress made in cell and stem cell biology, material sciences and tissue engineering enabled researchers to develop cutting-edge technology which has lead to the creation of nonmodular tissue constructs such as skin, bladders, vessels and upper airways. In all cases, autologous cells were seeded on either artificial or natural supporting scaffolds. However, such constructs were implanted without the reconstruction of the vascular supply, and the nutrients and oxygen were supplied by diffusion from adjacent tissues. Engineering of modular organs (namely, organs organized in functioning units referred to as modules and requiring the reconstruction of the vascular supply) is more complex and challenging. Models of functioning hearts and livers have been engineered using "natural tissue" scaffolds and efforts are underway to produce kidneys, pancreata and small intestine. Creation of custom-made bioengineered organs, where the cellular component is exquisitely autologous and have an internal vascular network, will theoretically overcome the two major hurdles in transplantation, namely the shortage of organs and the toxicity deriving from lifelong immunosuppression. This review describes recent advances in the engineering of several key tissues and organs. Transplant International

KW - decellularization

KW - extracellular matrix

KW - regenerative medicine

KW - scaffold

KW - solid organ transplantation

KW - stem cells

KW - tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=79551525410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551525410&partnerID=8YFLogxK

U2 - 10.1111/j.1432-2277.2010.01182.x

DO - 10.1111/j.1432-2277.2010.01182.x

M3 - Article

C2 - 21062367

AN - SCOPUS:79551525410

VL - 24

SP - 223

EP - 232

JO - Transplant International

JF - Transplant International

SN - 0934-0874

IS - 3

ER -